Representative before the EPO

Employment test 501 - 1000 employees
Company dna mintz levin cohn ferris glovsky and popeo pc
operating since 1933
Headquarter in Boston and 9 offices
active in Legal Services and IP Consulting

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 14 EP applications Beate Peter has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11794757

CD89 ACTIVATION IN THERAPY

IPC classification:
C07K 16/28, A61P 37/00, A61K 39/395
Applicant:
CSL Behring AG
Applicant:
University of Bern (Universit├Ąt Bern)
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP12167178

Sugar compositions for treating hemophilia a and/or von willebrand disease

IPC classification:
A61P 7/04, A61K 31/7008, A61K 31/7004, A61K 31/70
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
APPLICATION WITHDRAWN
EP12735916

INHIBITORY ANTI -FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES

IPC classification:
C07K 16/36
Applicant:
CSL Ltd.
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION IN PROGRESS
EP13164728

Complex

IPC classification:
A61K 47/48, A61K 38/37, C07K 14/755, A61P 7/04
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
The patent has been granted
EP13704770

VON WILLEBRAND FACTOR VARIANTS HAVING IMPROVED FACTOR VIII BINDING AFFINITY

IPC classification:
A61K 38/36, C12N 15/63, C07K 14/755
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
The patent has been granted
EP13708170

TREATMENT OF MUCOSITIS WITH IMMUNOGLOBULIN

IPC classification:
C07K 16/12, C07K 16/06, A61P 1/00
Applicant:
CSL Behring AG
Applicant:
University of Bern (Universit├Ąt Bern)
Agent:
Beate Peter, CSL Behring GmbH
Status:
The patent has been granted
EP13708787

PREVENTION OF INFECTION

IPC classification:
A61K 47/48, A61K 38/14, C07K 16/12
Applicant:
CSL Behring AG
Applicant:
Beth Israel Deaconess Medical Center Inc
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13708786

COMPOSITIONS COMPRISING SECRETORY-LIKE IMMUNOGLOBULINS

IPC classification:
A61K 39/395, C07K 16/06, C07K 14/435, A61P 31/04
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13708164

PROCESS FOR ENRICHING IGA

IPC classification:
C07K 16/06, C07K 16/00
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP13709917

SUGAR COMPOSITIONS FOR TREATING HEMOPHILIA A AND/OR VON WILLEBRAND DISEASE

IPC classification:
A61K 31/7008, A61K 31/7004, A61K 31/70, A61P 7/04
Applicant:
CSL Behring GmbH
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP14722135

COMPLEX

IPC classification:
A61P 7/04, C07K 14/755, A61K 47/48, A61K 38/37
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP14736713

PROCESS

IPC classification:
C07K 1/36, C07K 16/06
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
GRANT OF PATENT INTENDED
EP15715209

NEBULIZATION OF IMMUNOGLOBULIN

IPC classification:
A61M 11/00, A61K 9/00, A61K 47/18
Applicant:
Medizinische Hochschule Hannover
Applicant:
PARI Pharma GmbH
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
EXAMINATION REQUESTED
EP15805446

PHARMACEUTICAL PRODUCT WITH INCREASED STABILITY COMPRISING IMMUNOGLOBULINS

IPC classification:
C07K 16/00, C07K 1/00, A61M 5/178, A61K 39/395
Applicant:
CSL Behring AG
Agent:
Beate Peter, CSL Behring GmbH
Status:
Request for examination was made

Please Sign in to use this feature